Rocket


News + Filings
Transactions



Legorreta Pablo G.

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/29/2023PROKIDNEY CORP. GrantDirector stock option (right to buy)48.1k$10.56$508.2k 06/29/2023
06/28/2023Royalty Pharma plcRPRXPurchaseClass A ordinary shares130k$29.51$3.8MBy Legorreta 2023 SR Trust06/28/2023
05/24/2023Royalty Pharma plcRPRXPurchaseClass A ordinary shares150k$32.25$4.8MBy Legorreta 2023 SR Trust05/24/2023
05/17/2023Royalty Pharma plcRPRXPurchaseClass A ordinary shares69.6k$32.94$2.3MBy Legorreta 2023 SR Trust05/16/2023
05/16/2023Royalty Pharma plcRPRXPurchaseClass A ordinary shares160.4k$33.57$5.4MBy Legorreta 2023 SR Trust05/16/2023
05/12/2023Royalty Pharma plcRPRXGiftICAI Interests10.3k$0.00$0 05/12/2023
05/12/2023Royalty Pharma plcRPRXGiftICAI Interests10.3k$0.00$0By Spouse05/12/2023
08/12/2022Epizyme, Inc.EPZMOtherCommon Stock, par value $0.000131.9M$0.00$0See footnotes08/12/2022
08/12/2022Epizyme, Inc.EPZMDispositionRestricted Stock Units9k$0.00$0 08/12/2022
08/12/2022Epizyme, Inc.EPZMDispositionRestricted Stock Units8.1k$0.00$0 08/12/2022
07/11/2022PROKIDNEY CORP. GrantCommon Units in ProKidney LP94.7M$0.00$0See footnote07/11/2022
07/11/2022PROKIDNEY CORP. GrantEarnout Rights10.5M$0.00$0See footnote07/11/2022
05/17/2022Epizyme, Inc.EPZMGrantStock Option (Right to Buy)41k$0.56$23k 05/17/2022
05/17/2022Epizyme, Inc.EPZMGrantRestricted Stock Units9k$0.00$0 05/17/2022
04/14/2022Royalty Pharma plcRPRXOther (disposition)Class A Ordinary Shares462k$0.00$0By Legorreta Investments II LLC06/16/2020
04/14/2022Royalty Pharma plcRPRXOther (disposition)Class A Ordinary Shares350k$0.00$0 06/16/2020
01/31/2022Epizyme, Inc.EPZMPurchaseCommon Stock22.7M$1.50$34MSee footnotes01/31/2022
06/30/2021Royalty Pharma plcRPRXOther (acquisition)ICAI Interests73.3k$0.00$0 06/16/2020
06/11/2021Epizyme, Inc.EPZMGrantStock Option (Right to Buy)40.6k$8.53$346k 06/11/2021
06/11/2021Epizyme, Inc.EPZMGrantRestricted Stock Units8.1k$0.00$0 06/11/2021
05/07/2021Royalty Pharma plcRPRXConversionClass A Ordinary Shares1.3M$0.00$0By GST-Exempt Legorreta 2012 Family Trust05/07/2021
05/07/2021Royalty Pharma plcRPRXConversionClass A Ordinary Shares1M$0.00$0By Legorreta Children 2002 Trust05/07/2021
05/07/2021Royalty Pharma plcRPRXConversionLP interests in RPI US Partners 2019, LP104k$0.00$0By Legorreta Children 2002 Trust05/07/2021
05/07/2021Royalty Pharma plcRPRXConversionLP interests in RPI US Partners 2019, LP128.5k$0.00$0By GST-Exempt Legorreta 2012 Family Trust05/07/2021
03/23/2021Royalty Pharma plcRPRXOther (acquisition)LP interests in RPI US Partners 2019, LP15.9k$0.00$0By Legorreta Investments LLC06/16/2020
03/23/2021Royalty Pharma plcRPRXOther (acquisition)LP interests in RPI US Partners 2019, LP16k$0.00$0By Legorreta Investments II LLC06/16/2020
10/20/2020Royalty Pharma plcRPRXConversionClass A Ordinary Shares428.4k$0.00$0By Legorreta Investments LLC06/16/2020
10/20/2020Royalty Pharma plcRPRXConversionLP interests in RPI US Partners 2019, LP42.8k$0.00$0By Legorreta Investments LLC06/16/2020
06/18/2020Royalty Pharma plcRPRXConversionLP interests in RPI International Holdings 2019, LP12.3k$0.00$0By IRRA06/15/2020
06/18/2020Royalty Pharma plcRPRXConversionLP interests in RPI International Holdings 2019, LP11.8k$0.00$0By SEP/ IRA06/15/2020
06/18/2020Royalty Pharma plcRPRXPurchaseClass A Ordinary Shares10k$28.00$280kBy Child06/15/2020
06/18/2020Royalty Pharma plcRPRXConversionClass A Ordinary Shares123.3k$0.00$0By IRRA06/15/2020
06/18/2020Royalty Pharma plcRPRXConversionClass A Ordinary Shares118.5k$0.00$0By SEP/IRA06/15/2020
06/16/2020Royalty Pharma plcRPRXConversionClass A Ordinary Shares493.8k$0.00$0By Legorreta Investments LLC06/16/2020
06/16/2020Royalty Pharma plcRPRXConversionLP interests in RPI US Partners 2019, LP49.4k$0.00$0By Legorreta Investments LLC06/16/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy